Skip to Content

Immunosuppressants reduce COVID-19 vaccine efficacy in inflammatory disease patients

A Danish study found that immunosuppressive therapies, such as corticosteroids and rituximab, reduced the effectiveness of COVID-19 mRNA vaccines in patients with immune-mediated inflammatory diseases. Listen to MD Daniel Ward from Aalborg University elaborate.

Daniel Ward

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top